SOURCE: Acology Inc.

Acology Inc.

December 02, 2014 08:00 ET

Acology, Inc. Announces Letter to Shareholders

Letter Provides Corporate Objectives and Details the Company's Development Programs for Their Proprietary Product "The Medtainer" That Serve the Pharmaceutical, Veterinary, and Medical Marijuana Markets

CORONA, CA--(Marketwired - December 02, 2014) - Acology, Inc. (OTCQB: ACOL), maker of the first-ever polypropylene (PP) airtight, watertight, smell-proof medical grade container, announced today the Company has issued a letter to its shareholders. In the letter, Acology's Chief Executive Officer, Curtis Fairbrother, updates shareholders on the company's efforts to increase shareholder value related to its key initiatives and developments, which include:

  • Mainstream commercialization of the Medtainer for use in the Pharmaceutical market.  The company is currently signing distribution agreements pursuant to which The Medtainer will use regional and national sale channels for large scale distribution.
  • Targeted growth of the Medtainer in the multi-billion dollar veterinary market. 
  • Global acceptance of The Medtainer as the first standardized medical grade container for the Medical and Recreational Medical Marijuana Market.  Compliance initiatives are in motion to provide the first airtight, watertight, smell-proof medical grade container that state governments can utilize as the standard container in the industry.

Chief Executive Officer Curtis Fairbrother stated, "Overall, our primary objective is to commercialize our proprietary medical grade container across multiple market sectors and increase shareholder value.  As we mature as a public company we have new shareholders coming on board every day that are investing and supporting our developmental efforts.  Doug Heldoorn, Acology's Chief Operating Officer, and I will work diligently to keep all of our shareholders informed about our progress and the work we are doing to bring the Medtainer and our growing product line to market. I would also like to take this opportunity to thank every member of our team that, through hard work and dedication, have contributed to our current and future success."

Acology's 4th generation Medtainer is a patented, FDA approved #5 polypropylene container that is water-proof, smell-proof and child resistant. Its most dynamic feature is a built-in grinder that grinds pills, herbal medications, coffee beans and teas into fine powder. The container's grinding teeth have been reinforced for greater wear and easier manipulation.

Acology Inc. is located in their new production facility at 1620 A Commerce Street, Corona, California, 92880. Acology trades on the OTCQB as ACOL.  Contact us at info@acologyinc.com or call (844) ACOLOGY

For more information on Acology, Inc.: www.acologyinc.com

For more information on the Medtainer: www.medtainer.com 

About Acology Inc.

Acology, Inc. is a revolutionary bottle design, manufacturing, branding and sales company bringing to the forefront the first-ever polypropylene (PP) airtight, watertight, smell-proof delivery and storage system with a built-in grinding component. Acology containers give consumers the ability to easily store, carry and consume herbal remedies, pharmaceuticals, teas and any other solid or liquid content. Because Acology Inc. adheres so closely to the rigid compliance standards of the medical industry it can provide the medical professional with the ability to store, mix and distribute medications in solid form without the fear of cross-contamination. 

Safe Harbor Statement

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.  

Contact Information